| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |